Genome-Wide RNAi Screening Identifies Novel Pathways/Genes Involved in Oxidative Stress and Repurposable Drugs to Preserve Cystic Fibrosis Airway Epithelial Cell Integrity
Open Access
- 2 December 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (12) , 1936
Abstract
Recurrent infection-inflammation cycles in cystic fibrosis (CF) patients generate a highly oxidative environment, leading to progressive destruction of the airway epithelia. The identification of novel modifier genes involved in oxidative stress susceptibility in the CF airways might contribute to devise new therapeutic approaches. We performed an unbiased genome-wide RNAi screen using a randomized siRNA library to identify oxidative stress modulators in CF airway epithelial cells. We monitored changes in cell viability after a lethal dose of hydrogen peroxide. Local similarity and protein-protein interaction network analyses uncovered siRNA target genes/pathways involved in oxidative stress. Further mining against public drug databases allowed identifying and validating commercially available drugs conferring oxidative stress resistance. Accordingly, a catalog of 167 siRNAs able to confer oxidative stress resistance in CF submucosal gland cells targeted 444 host genes and multiple circuitries involved in oxidative stress. The most significant processes were related to alternative splicing and cell communication, motility, and remodeling (impacting cilia structure/function, and cell guidance complexes). Other relevant pathways included DNA repair and PI3K/AKT/mTOR signaling. The mTOR inhibitor everolimus, the α1-adrenergic receptor antagonist doxazosin, and the Syk inhibitor fostamatinib significantly increased the viability of CF submucosal gland cells under strong oxidative stress pressure. Thus, novel therapeutic strategies to preserve airway cell integrity from the harsh oxidative milieu of CF airways could stem from a deep understanding of the complex consequences of oxidative stress at the molecular level, followed by a rational repurposing of existing “protective” drugs. This approach could also prove useful to other respiratory pathologies.Keywords
Funding Information
- Generalitat de Catalunya (CERCA Programme, 2014SGR541)
- Associació Catalana de Fibrosi Quística (Personal Grants)
- Instituto de Salud Carlos III (PTA2018-016371-I, CA18/00045, PI13/01490 and PI16/00377)
- Instituto de Salud Carlos III and Government of Catalonia (CES06/012)
This publication has 100 references indexed in Scilit:
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- p53, Oxidative Stress, and AgingAntioxidants & Redox Signaling, 2011
- The DNA Damage Response Pathway Regulates the Alternative Splicing of the Apoptotic Mediator Bcl-xJournal of Biological Chemistry, 2011
- Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatinThe EMBO Journal, 2010
- Cotranscriptional exon skipping in the genotoxic stress responseNature Structural & Molecular Biology, 2010
- An Alternative Splicing Network Links Cell-Cycle Control to ApoptosisCell, 2010
- Cdc5L interacts with ATR and is required for the S‐phase cell‐cycle checkpointEMBO Reports, 2009
- Fluid secretion by submucosal glands of the tracheobronchial airwaysRespiratory Physiology & Neurobiology, 2007
- Parasympathetic control of airway submucosal glands: Central reflexes and the airway intrinsic nervous systemAutonomic Neuroscience, 2007
- A Greedy Algorithm for Aligning DNA SequencesJournal of Computational Biology, 2000